Skip to main content

Table 1 Demographic and Treatment Characteristics (N = 102)

From: Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients

Variable

N (%)

Age (Mean, SD, Median)

57.0 (13.5) 57

Ethnicity

 

   Caucasian

73 (71.6%)

   African American

26 (25.5%)

   Other

2 (2.0%)

   Unknown

1 (1.0%)

BMI (Mean, SD, Median)

29.0 (6.5) 28.0

Had Prior Breast Cancer Surgery

89 (87.3%)

Had Prior Radiation Therapy

73 (71.6%)

Had Prior Neoadjuvant Therapy

16 (15.7%)

Had Prior Adjuvant Therapy

63 (61.8%)

First Line Therapy

 

   None Reported

4 (3.9%)

   Hormonal Therapy Only

30 (29.4%)

   Taxane Based Therapy

43 (42.0%)

   Non-Taxane Based Therapy

25 (25.0%)

   Had Toxicity Related Discontinuation

7 (6.9%)

Received Second Line Therapy

92 (90.1%)

   Had Toxicity Related Discontinuation

6 (6.5%)